STTK Shattuck Labs, Inc.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1680367 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-66.6%
TTM net income YoY14.5%
TTM EPS YoY63.6%
Revenue 3-yr CAGR5.2%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-5,578.7%
Net margin-5,256.8%
FCF margin—
EBITDA margin-5,221.0%
Returns
ROE-39.2%
ROA-36.9%
ROIC (approx.)-57.1%
Asset turnover0.01x
Leverage & solvency
Liabilities / assets4.3%
Debt / equity0.00x
Current ratio27.59x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.78x
Accruals ratio-8.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.00M | $5.72M |
| R&D expense | $35.27M | $67.21M |
| SG&A expense | $17.23M | $19.08M |
| Operating income | -$51.51M | -$80.57M |
| Income tax | $0 | $0 |
| Net income | -$48.81M | -$75.41M |
| EBITDA | -$47.81M | -$76.77M |
| EPS (basic) | -0.70 | -1.49 |
| EPS (diluted) | -0.70 | -1.49 |
| Weighted avg. shares (diluted) | 69.58M | 50.76M |
| Balance sheet | ||
| Cash & equivalents | $54.19M | $57.39M |
| Current assets | $82.47M | $79.22M |
| PP&E, net | $6.11M | $9.81M |
| Total assets | $91.03M | $91.05M |
| Current liabilities | $7.05M | $8.92M |
| Total liabilities | $8.64M | $11.42M |
| Shareholders' equity | $82.39M | $79.63M |
| Shares outstanding | 63.28M | 47.71M |
| Cash flow statement | ||
| Operating cash flow | -$39.88M | -$60.52M |
| Capital expenditure | $71,000 | $59,000 |
| Free cash flow | -$39.95M | -$60.57M |
| Investing cash flow | -$7.89M | -$8.51M |
| Financing cash flow | $44.57M | $787,000 |
| Depreciation & amortization | $3.70M | $3.80M |
| Stock-based compensation | $7.00M | $9.55M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.